Arrow Financial Corp Gilead Sciences, Inc. Transaction History

Arrow Financial Corp

$1.07 Billion
Q3 2024

A detailed history of Arrow Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arrow Financial Corp holds 619 shares of GILD stock, worth $55,827. This represents 0.0% of its overall portfolio holdings.

Number of Shares

619

Previous 1,158 46.55%

Holding current value

$55,827

Previous $79,000 35.44%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$66.59 - $83.99 $35,892 - $45,270	-539 Reduced 46.55%	619 $51,000
Q1 2024 May 21, 2024	SELL	$71.58 - $87.29 $71 - $87	-1 Reduced 0.09%	1,158 $84,000
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $14,654 - $16,618	-200 Reduced 14.72%	1,159 $93,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $27,743 - $31,645	-365 Reduced 21.17%	1,359 $104,000
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $51,725 - $74,260	-830 Reduced 32.5%	1,724 $148,000
Q2 2022 Jul 25, 2022	SELL	$57.72 - $65.01 $49,927 - $56,233	-865 Reduced 25.3%	2,554 $157,000
Q1 2022 Apr 26, 2022	SELL	$57.92 - $72.58 $85,258 - $106,837	-1,472 Reduced 30.1%	3,419 $204,000
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $526,306 - $597,367	-8,112 Reduced 62.39%	4,891 $354,000
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $2,504 - $2,702	-37 Reduced 0.28%	13,003 $909,000
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $16,121 - $17,614	254 Added 1.99%	13,040 $898,000
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $38,940 - $44,430	649 Added 5.35%	12,786 $827,000
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $58,236 - $66,357	1,028 Added 9.25%	12,137 $707,000
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $47,071 - $59,184	-758 Reduced 6.39%	11,109 $702,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $12,876 - $14,952	-178 Reduced 1.48%	11,867 $913,000
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $10,271 - $13,156	164 Added 1.38%	12,045 $901,000
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $124,780 - $137,254	2,025 Added 20.55%	11,881 $771,000
Q3 2019 Oct 28, 2019	BUY	$62.51 - $69.0 $85,013 - $93,840	1,360 Added 16.01%	9,856 $625,000
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $33,842 - $37,950	547 Added 6.88%	8,496 $574,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $13,131 - $14,710	210 Added 2.71%	7,949 $517,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $8,475 - $11,060	-140 Reduced 1.78%	7,739 $483,000
Q3 2018 Oct 11, 2018	BUY	$71.28 - $78.92 $6,415 - $7,102	90 Added 1.16%	7,879 $609,000
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $170,180 - $198,508	-2,623 Reduced 25.19%	7,789 $551,000
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $49,968 - $60,916	686 Added 7.05%	10,412 $786,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $37,353 - $43,848	525 Added 5.71%	9,726 $697,000
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $663,484 - $786,409	9,201	9,201 $746,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.

Account

Arrow Financial Corp Gilead Sciences, Inc. Transaction History